| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |